跳至主要内容
临床试验/NCT02689583
NCT02689583Unknown不适用

A Multi-center Study for Individual Treatment of Helicobacter Pylori Infection

First Affiliated Hospital of Zhejiang University0 个研究点目标入组 3,000 人开始时间: 2016年3月1日最近更新:
适应症

试验速览

阶段
不适用
发起方
入组人数
3,000
主要终点
Eradication rates

研究概览

简要总结

Since the discovery of Helicobacter pylori (H. pylori), many studies have been carried out with the goal of improving H. pylori eradication and therapies have changed from single-antibiotic treatments to the current multi-antibiotic treatments. However, the eradication rate of H. pylori is still less than 80%. The reasons for this low eradication rate are likely to be multi-factorial, including the reduced activity of antimicrobial drugs, poor patient compliance or micro-environment in stomach. In this study, to obtain the higher eradication of H. pylori and discover the different mechanism between the current infection and refractory infection of H. pylori, it is necessary to perform a prevalence survey for eradication of H. pylori based on the results from isolation of H. pylori strains, antibiotic susceptibility testing, CYP2C19 gene polymorphism, drug resistance gene sequencing and 16SrRNA sequencing.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Participant)

入排标准

年龄范围
18 Years 至 70 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age 18~70 years old, male or female, untreated patients.
  • Symptoms of abdominal pain, bloating, acid reflux, belching, nausea, vomiting, heartburn, chest pain, vomiting, melena, etc.
  • Unused antibiotics, bismuth, H2 receptor antagonists or PPI by nearly 4 weeks
  • 13C-labelled urea breath test positive.
  • 5.Agreed to Helicobacter pylori culture and sensitivity testing taken by endoscopy gastric biopsy specimens,and the result of culture was positive.
  • 6.Agreed to Helicobacter pylori eradication therapy and cooperate with the eradication efficacy follow-up survey.

排除标准

  • Severe heart, liver, kidney dysfunction.
  • Pregnant or lactating women.
  • Complications of bleeding, perforation, pyloric obstruction, cancer.
  • Esophageal,gastrointestinal surgery history.
  • Patients can not properly express their complaints,such as psychosis, severe neurosis.
  • Taking NSIAD or alcohol abusers.
  • Allergic to penicillin or either drugs of the 6 antibiotic tested by susceptibility testing.

结局指标

主要结局

Eradication rates

时间窗: Three months

To investigate the eradication rates of H.Pylori after individual quadruple therapy based on antibiotic susceptibility testing, CYP2C19 gene polymorphism, drug resistance gene sequencing and 16SrRNA sequencing.

Mutation site of drug resistance gene

时间窗: Three months

To discover the difference of mutation site in drug resistance gene between successful patients and refractory patients by second-generation sequencing.

The distribution and proportion of microflora in stomach

时间窗: Three months

To discover the distribution and proportion of microflora in stomach between successful patients and refractory patients of H. Pylori infection by 16SrRNA sequencing.

次要结局

未报告次要终点

研究者

发起方
First Affiliated Hospital of Zhejiang University
申办方类型
Other
责任方
Principal Investigator
主要研究者

Youming Li

Director of the Department of Gastroenterology

First Affiliated Hospital of Zhejiang University

相似试验